Search
Skip to Search Results- 2Hegadoren, Kathleen M.
- 1Adu, Medard Kofi
- 1Al-Ghamdi,Mohammad S
- 1Al-Nuaimi, Saleem K
- 1Amritraj, Asha
- 1Amusan, Precious
-
Fall 2023
This is a comprehensive examination of the diagnostic landscape in psychiatry and the role precision psychiatry might play in redefining how we classify illnesses. This thesis delves into three areas that currently exist in psychiatry today and is divided into five chapters. The first and second...
-
Improving Child and Adolescent Mental Health Services: A Qualitative and Quantitative Exploration into the Current State of Services in Alberta, Canada
DownloadSpring 2023
Background There is a paucity of evidence-based research aimed at determining best-practice treatment in the context of child and adolescent mental health services (CAMHS). Despite the high prevalence of mental illness in youth, no gold-standard for treatment currently exists. Assessment tools...
-
Pharmacogenomics for Psychiatry: Focusing on Drug Metabolizing Enzymes and Transporters, with Validated Methodology for CYP2D6 and CYP2C19 Including for a Novel Sub-Haplotype
DownloadSpring 2022
Pharmacogenomics (PGx) is interested in the impact individual genetic makeup has on a patient’s response to pharmacological agents. In clinical practice, PGx has the potential of reducing adverse drug reactions (ADRs), which cost Canada $65 million dollars in the year 2018, as well as enhancing...
-
Fall 2022
Background: Most discharged psychiatric patients in Alberta are offered follow-up appointments with Alberta Health Services (AHS) Addiction and Mental Health (A&MH) community providers. It is typical to wait weeks or months for a follow-up appointment, resulting in a substantial psychological...
-
Repetitive Transcranial Magnetic Stimulation with and without Internet-delivered Cognitive Behaviour Therapy for the Treatment of Resistant Depression: Patient-centred Randomized Controlled Pilot Trial
DownloadFall 2022
Abstract Background: Major depression is a severe, disabling, and potentially lethal clinical disorder. Only about half of patients respond to an initial course of antidepressant pharmacotherapy. At least 15% of patients with major depression disorder (MDD) remain refractory to any treatment...
-
Fall 2022
Suicide is a serious public health issue resulting in high mortality rates around the world. Trauma and adversity are strongly correlated with suicidal thoughts and behaviours. Memories associated with past trauma can contribute to significant distress in the present, creating a desire to escape...
-
Mental health and addiction problems among vulnerable populations and the impact of a supportive text message intervention in one vulnerable group
DownloadFall 2022
Background Mental health and addiction problems are prevalent among some groups such as the military, firefighters, the elderly, and residents who have experienced multiple disasters. Identifying the prevalence and predictors of mental health and addiction conditions is important for primary...
-
The interaction of phenelzine with human monoamine oxidase B: characterization and consequences
DownloadSpring 2022
Phenelzine (PLZ) is a monoamine oxidase (MAO) inhibitor developed in the 1960s which has been used clinically for psychiatric conditions such as depression and anxiety disorders. However, despite over 60 years of research, the mechanism by which PLZ exerts its effects on MAO has yet to be...
-
A multi-methods exploration of shared decision-making, lived experience, and opioid use disorder among emerging adults with anxiety and depression
DownloadFall 2021
Background Anxiety/depression are common in emerging adults and may lead to poor coping strategies such as substance use. Shared decision-making (SDM) occurs when clinicians and patients make health decisions together informed by the best available evidence inclusive of the patient’s...